Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 16K | $3.13M | $195.00 | Dec 27, 2023 | Direct |
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 4K | $626K | $156.54 | Dec 27, 2023 | by Trust |
BRISTOL MYERS SQUIBB CO | Director | Common Stock, $0.10 par value | 12.5K | $622K | $49.78 | Jun 13, 2021 | Direct |
BRISTOL MYERS SQUIBB CO | Director | Deferred Share Units | 9.34K | $479K | $51.31 | Jun 30, 2021 | Direct |
BRISTOL MYERS SQUIBB CO | Director | Common Stock, $0.10 par value | 2K | $99.6K | $49.78 | Jun 13, 2021 | By Trust |
Magenta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18.2K | Jun 1, 2021 | Direct | ||
Kaleido Biosciences, Inc. | Director | Stock Option (Right to Buy) | 15K | Jun 30, 2020 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 5.23K | May 16, 2024 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 0 | Aug 2, 2023 | Direct | ||
BRISTOL MYERS SQUIBB CO | Director | Restricted Stock Units | 0 | $50.10 | Jun 13, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Dec 27, 2023 | 3 | -$2.96M | 4 | Dec 29, 2023 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Aug 2, 2023 | 9 | -$1.2M | 4 | Aug 4, 2023 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Aug 2, 2021 | 1 | $0 | 4 | Aug 3, 2021 | Executive Chair, Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
BMY | BRISTOL MYERS SQUIBB CO | Jun 30, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
KLDO | Kaleido Biosciences, Inc. | Jun 30, 2021 | 2 | $0 | 4 | Jul 1, 2021 | Director |
BMY | BRISTOL MYERS SQUIBB CO | Jun 13, 2021 | 2 | $0 | 4 | Jun 14, 2021 | Director |
BMY | BRISTOL MYERS SQUIBB CO | Jun 3, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
MGTA | Magenta Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |